Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 01/03/18 |
James Kinley
DFI | Director of Finance/CFO | 45 | 01/12/21 |
Chief Operating Officer | 41 | 01/03/21 | |
Ahmad Khalil
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 08/09/21 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 01/03/18 |
Mark Williams
BRD | Director/Board Member | 52 | 22/09/21 |
James Kinley
DFI | Director of Finance/CFO | 45 | 01/12/21 |
Raj Attariwala
BRD | Director/Board Member | 55 | 26/10/15 |
Howard Gutman
BRD | Director/Board Member | - | 28/02/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 21 840 722 | 21 665 319 ( 99,20 %) | 0 | 99,20 % |
Coordinate società
Algernon Pharmaceuticals, Inc.
601 West Broadway Street Suite 400
V5Z 4C2, Vancouver
+604-398-4175
http://www.algernonpharmaceuticals.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+9,58% | 115 Mrd | |
+12,41% | 107 Mrd | |
-12,38% | 22,31 Mrd | |
-3,41% | 21,6 Mrd | |
-3,35% | 18,23 Mrd | |
-38,57% | 17,62 Mrd | |
+7,51% | 14,26 Mrd | |
+35,67% | 12,37 Mrd | |
-24,50% | 8,28 Mrd |